These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 1390245)

  • 1. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
    Heddle NM; O'Hoski P; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1992 Aug; 81(4):579-84. PubMed ID: 1390245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.
    Pinkerton PH; Coovadia AS; Goldstein J
    Transfusion; 1992; 32(9):814-7. PubMed ID: 1471244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted?
    Judd WJ; Fullen DR; Steiner EA; Davenport RD; Knafl PC
    Transfusion; 1999 Mar; 39(3):295-9. PubMed ID: 10204593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a manual hexadimethrine bromide-antiglobulin test with saline- and albumin-antiglobulin tests for pretransfusion testing.
    Mintz PD; Anderson G
    Transfusion; 1987; 27(2):134-7. PubMed ID: 3824470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and cost-containment data that advocate abbreviated pretransfusion testing.
    Cordle DG; Strauss RG; Snyder EL; Floss AM
    Am J Clin Pathol; 1990 Oct; 94(4):428-31. PubMed ID: 2220670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hemolytic reaction implicating Sda antibody missed by immediate spin crossmatch.
    Reznicek MJ; Cordle DG; Strauss RG
    Vox Sang; 1992; 62(3):173-5. PubMed ID: 1609519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type and screen method and Coombs crossmatch method for pretransfusion testing: A prospective comparative study in a tertiary care hospital in Delhi.
    Anu KD; Pahuja S; Sharma G
    Asian J Transfus Sci; 2022; 16(1):83-88. PubMed ID: 36199420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the indirect antiglobulin crossmatch justified?
    Peterson DM; Roxby DJ; Seshadri R
    Pathology; 1987 Apr; 19(2):121-3. PubMed ID: 3502613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited.
    Judd WJ; Barnes BA; Steiner EA; Oberman HA; Averill DB; Butch SH
    Transfusion; 1986; 26(3):220-4. PubMed ID: 3705135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the crossmatch in testing for serologic incompatibility.
    Oberman HA; Barnes BA; Steiner EA
    Transfusion; 1982; 22(1):12-6. PubMed ID: 6801826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with the routine use of an abbreviated crossmatch.
    Shulman IA; Nelson JM; Saxena S; Thompson JC; Okamoto M; Kent DR; Nakayama RK
    Am J Clin Pathol; 1984 Aug; 82(2):178-81. PubMed ID: 6465079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative utility of the autologous control and the antiglobulin test phase of the crossmatch.
    Perkins JT; Arruza M; Fong K; Sosler SD; Saporito C
    Transfusion; 1990; 30(6):503-7. PubMed ID: 2378021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reappraisal of pre-transfusion testing procedures in a hospital blood bank.
    Lown JA; Barr AL; Jackson JM
    Pathology; 1985 Jul; 17(3):489-92. PubMed ID: 4069768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransfusion blood group serology. Limited value of the antiglobulin phase of the crossmatch when a careful screening test for unexpected antibodies is performed.
    Heistø H
    Transfusion; 1979; 19(6):761-3. PubMed ID: 118557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with a cost-effective crossmatch protocol.
    Shulman IA; Nelson JM; Kent DR; Jacobs VL; Nakayama RK; Malone SA
    JAMA; 1985 Jul; 254(1):93-5. PubMed ID: 3999355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.
    Tiwari AK; Aggarwal G; Dara RC; Arora D; Gupta GK; Raina V
    Asian J Transfus Sci; 2017; 11(1):40-44. PubMed ID: 28316439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch.
    Shulman IA
    Arch Pathol Lab Med; 1990 Apr; 114(4):412-4. PubMed ID: 2322101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-i causing acute hemolysis following a negative immediate-spin crossmatch.
    Judd WJ; Steiner EA; Abruzzo LV; Davenport RD; Oberman HA; Pehta JC; Nance SJ
    Transfusion; 1992; 32(6):572-5. PubMed ID: 1502712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective platelet crossmatching for selection of compatible random donors.
    Freedman J; Hooi C; Garvey MB
    Br J Haematol; 1984 Jan; 56(1):9-18. PubMed ID: 6367808
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.